Letter: the sphingosine 1 phosphate/sphingosine 1 phosphate receptor axis-a unique therapeutic target in inflammatory bowel disease
- PMID: 35472180
- DOI: 10.1111/apt.16888
Letter: the sphingosine 1 phosphate/sphingosine 1 phosphate receptor axis-a unique therapeutic target in inflammatory bowel disease
Comment in
-
Letter: the sphingosine 1 phosphate/sphingosine 1 phosphate receptor axis-a unique therapeutic target in inflammatory bowel disease. Authors' reply.Aliment Pharmacol Ther. 2022 May;55(10):1360. doi: 10.1111/apt.16919. Aliment Pharmacol Ther. 2022. PMID: 35472188 No abstract available.
Comment on
-
Review article: the sphingosine 1 phosphate/sphingosine 1 phosphate receptor axis - a unique therapeutic target in inflammatory bowel disease.Aliment Pharmacol Ther. 2022 Feb;55(3):277-291. doi: 10.1111/apt.16741. Epub 2021 Dec 21. Aliment Pharmacol Ther. 2022. PMID: 34932238 Free PMC article. Review.
Similar articles
-
Letter: the sphingosine 1 phosphate/sphingosine 1 phosphate receptor axis-a unique therapeutic target in inflammatory bowel disease. Authors' reply.Aliment Pharmacol Ther. 2022 May;55(10):1360. doi: 10.1111/apt.16919. Aliment Pharmacol Ther. 2022. PMID: 35472188 No abstract available.
-
Sphingosine-1-Phosphate Signaling in Inflammatory Bowel Disease.Trends Mol Med. 2017 Apr;23(4):362-374. doi: 10.1016/j.molmed.2017.02.002. Epub 2017 Mar 8. Trends Mol Med. 2017. PMID: 28283249 Review.
-
Targeting the Sphingosine-1-Phosphate Pathway: New Opportunities in Inflammatory Bowel Disease Management.Drugs. 2024 Oct;84(10):1179-1197. doi: 10.1007/s40265-024-02094-5. Epub 2024 Sep 26. Drugs. 2024. PMID: 39322927 Free PMC article. Review.
-
Targeting the Sphingosine-1-Phosphate Axis for Developing Non-narcotic Pain Therapeutics.Trends Pharmacol Sci. 2020 Nov;41(11):851-867. doi: 10.1016/j.tips.2020.09.006. Epub 2020 Oct 1. Trends Pharmacol Sci. 2020. PMID: 33010954 Free PMC article. Review.
-
What Is the Role of Sphingosine-1-Phosphate Receptors in Pain?Neurology. 2021 Mar 16;96(11):525-528. doi: 10.1212/WNL.0000000000011605. Neurology. 2021. PMID: 33723022 Review. No abstract available.
References
REFERENCES
-
- Wang J, Goren I, Yang B, Lin S, Li J, Elias M, et al. Review article: the sphingosine 1 phosphate/sphingosine 1 phosphate receptor axis-a unique therapeutic target in inflammatory bowel disease. Aliment Pharmacol Ther. 2022;55:277-91.
-
- Radeke HH, Stein J, Van Assche G, et al. A multicentre, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy, safety, and tolerability of the S1P receptor agonist KRP203 in patients with moderately active refractory ulcerative colitis. Inflamm Intest Dis. 2020;5(4):180-90.